Physician profile
Benjamin Young
NPI 1437371721
$4,156.49
in general payments reported to CMS, 2019-2025
14 companies · $866 in 2025
The $866 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,458 · 2020: $140 · 2021: $194 · 2022: $1,390 · 2023: $55.49 · 2024: $52.83 · 2025: $866.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $866 · Food and Beverage: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $865.94 |
| Food and Beverage | $108.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $2,779.45 | 2019-2022 | |
| Think Surgical, INC. | $865.94 | 2025 | |
| Medacta USA, INC. | $86.15 | 2022 | |
| Stryker Corporation | $74.30 | 2020 | |
| Pacira Therapeutics, INC. | $74.12 | 2020-2021 | |
| Ferring Pharmaceuticals INC. | $54.07 | 2023-2024 | Euflexxa |
| Orthalign INC | $46.01 | 2022 | |
| Depuy Synthes Sales INC. | $40.75 | 2022-2023 | Orthovisc |
| Vertex Pharmaceuticals Incorporated | $33.76 | 2024 | |
| Next Science LLC | $30.71 | 2021 | |
| Medtronic USA, INC. | $23.46 | 2020 | |
| Mallinckrodt Enterprises LLC | $17.97 | 2019 | |
| Bioventus LLC | $15.80 | 2022 | |
| Shire North American Group INC | $14.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.